Effects of testosterone-augmented multimodal exercise intervention in spinal cord injury: a randomized controlled trial
The Journal of Clinical Endocrinology & Metabolism · 2026
DOI: 10.1210/clinem/dgag173 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2026. Verfasst von Kieran F Reid und 16 weiteren Autor:innen. Beteiligte Einrichtung: Research Program in Men's Health: Aging and Metabolism, Boston Claude D. Pepper Older Americans Independence Center for Function Promoting Therapies,…. Hauptthemen laut MEDLINE: Spinal Cord Injuries, Testosterone, Exercise Therapy. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH HHS.
Abstract (Originalsprache)
Context
Spinal cord injury (SCI) leads to profound muscle atrophy, aerobic deconditioning, and metabolic dysfunction. Exercise-based interventions alone produce modest benefits. Whether testosterone can augment physiologic responses to exercise in this population remains untested.
Objective
To evaluate efficacy and safety of home-based intervention combining functional electrical stimulation–assisted leg cycling (FES-LC), arm ergometry (AE), and testosterone compared with FES-LC, AE plus placebo in adults with SCI.
Methods
This randomized, placebo-controlled, double-blind trial enrolled 84 adults (76 males and 8 females) aged 19-70 years with SCI (neurologic levels C4-T12; AIS grades A-D). Participants were randomized to multimodality intervention (home-based FES-LC, AE and intramuscular testosterone undecanoate) (n = 38) or control intervention (FES-LC, AE plus placebo) (n = 46) for 16 weeks. The primary outcome was change in aerobic capacity (peak VO2) during AE cardiopulmonary exercise testing. Secondary outcomes included lean mass, hemoglobin, cardiometabolic markers, and safety.
Results
Mean (SD) age was 44 (13) years and time since injury was 13.9 (13) years). Between-group changes in peak VO2 were not statistically significant. Within-group improvements were larger in multimodality (∼19% increase; 0.10 L/min; 95% CI, 0.02-0.18 L/min) compared to controls (∼6% increase; 0.06 L/min; 95% CI, –0.01-0.13). The multimodality group gained significantly more lean mass (whole-body:1.84 kg, 95% CI: 0.52-3.16, P = .007; lower extremity 0.92 kg, 95% CI: 0.38-1.45, P = .001), and anemia was corrected in a greater proportion of participants. Adverse event rates were similar between groups.
Conclusion
A home-based multimodality intervention combining FES-LC, AE, and testosterone was safe and associated with greater improvements in lean mass and hemoglobin. Although between-group differences in aerobic capacity were not statistically significant, greater within-group increases were observed in the multimodality group. These findings may inform future studies of testosterone-augmented exercise interventions for individuals living with SCI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research Program in Men's Health: Aging and Metabolism, Boston Claude D. Pepper Older Americans Independence Center for Function Promoting Therapies, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 0211…
- Laboratory of Exercise Physiology and Physical Performance, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
- Center for Clinical Spectroscopy, Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
- Department of Physical Medicine and Rehabilitation and Anesthesiology, University of Missouri School of Medicine, Columbia, MO 65212, USA.
ORCID-Profile: Kieran F Reid, Shalender Bhasin
Förderung
- NIA NIH HHS
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
- NIH HHS
- Boston Claude D. Pepper Older Americans Independence Center
- Harvard Clinical Translational Science Center
- National Institutes of Health
Zitieren
APA
Reid, K. F., Storer, T. W., Pencina, K. M., Ghattas, C., Shang, Y. V., Gavin, C., Valderrábano, R. J., Latham, N. K., Bracken, E. M., Lemay, L., Chandra, M. S., Skeels, S. E., Singh, Y., Bajdek, N., Lin, A. P., Zafonte, R. D., & Bhasin, S. (2026). Effects of testosterone-augmented multimodal exercise intervention in spinal cord injury: a randomized controlled trial. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgag173
Vancouver
Reid KF, Storer TW, Pencina KM, Ghattas C, Shang YV, Gavin C, et al. Effects of testosterone-augmented multimodal exercise intervention in spinal cord injury: a randomized controlled trial. The Journal of Clinical Endocrinology & Metabolism. 2026. doi:10.1210/clinem/dgag173
BibTeX
@article{Reid2026,
author = {Reid, Kieran F and Storer, Thomas W and Pencina, Karol M and Ghattas, Catherine and Shang, Yili V and Gavin, Connor and Valderrábano, Rodrigo J and Latham, Nancy K and Bracken, Eric M and Lemay, Lauren and Chandra, Mohan S and Skeels, Sarah E and Singh, Yashi and Bajdek, Nicole and Lin, Alexander P and Zafonte, Ross D and Bhasin, Shalender},
title = {Effects of testosterone-augmented multimodal exercise intervention in spinal cord injury: a randomized controlled trial},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2026},
doi = {10.1210/clinem/dgag173}
}
EUVIMED